S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway

被引:13
|
作者
Zheng, Susu [1 ,2 ]
Shen, Hujia [1 ,2 ]
Jia, Qingan [1 ,2 ]
Jing, Chuyu [1 ,2 ]
Lin, Jiajia [1 ,2 ]
Zhang, Meixia [1 ,2 ]
Zhang, Xiaolei [3 ]
Zhang, Boheng [1 ,2 ]
Liu, Yinkun [1 ,2 ]
机构
[1] Fudan Univ, Liver Canc Inst, Dept Hepat Oncol, Shanghai 20032, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai 20032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 20032, Peoples R China
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; prognosis; proliferation; S100A6; HUMAN HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; THERAPEUTIC TARGET; MAPK PATHWAYS; EXPRESSION; PROTEIN; KINASE; CALCYCLIN; MIGRATION; GROWTH;
D O I
10.2217/fon-2017-0199
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: We explored the expression of S100A6 and its role in intrahepatic cholangiocarcinoma (ICC). Methods: The expression of S100A6 in ICC samples was detected by immunohistochemistry. In vitro experiments, we silenced and overexpressed S100A6 to investigate its role in cell functions. Results: The expression of S100A6 was markedly increased in ICC tissues and cell lines. S100A6 overexpression was an independent risk factor for patients' survival. Silencing S100A6 resulted in a suppression of proliferation and p38/MAPK activity, while overexpressing S100A6 caused a promotion of proliferation and p38/MAPK. Discussion: S100A6 participated in the proliferation of ICC cells and correlated with a more aggressive behavior of ICC. Conclusion: S100A6 may serve as a novel prognostic marker and a potential therapeutic target for ICC patients.
引用
收藏
页码:2053 / 2063
页数:11
相关论文
共 50 条
  • [1] S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma
    Zhang, Mei-xia
    Gan, Wei
    Jing, Chu-yu
    Zheng, Su-su
    Yi, Yong
    Zhang, Juan
    Xu, Xin
    Lin, Jia-jia
    Zhang, Bo-heng
    Qiu, Shuang-jian
    MOLECULAR CARCINOGENESIS, 2019, 58 (01) : 19 - 30
  • [2] S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway
    Li, Anchuan
    Shi, Dingbo
    Xu, Benhua
    Wang, Jingshu
    Tang, Yan-Lai
    Xiao, WeiWei
    Shen, Guanzhu
    Deng, Wuguo
    Zhao, Chong
    MOLECULAR CARCINOGENESIS, 2017, 56 (03) : 972 - 984
  • [3] S100P regulates trophoblast-like cell proliferation via P38 MAPK pathway
    Zhu, Hai-Yan
    Wang, Jun-Xia
    Tong, Xiao-Mei
    Xue, Ya-Mei
    Zhang, Song-Ying
    GYNECOLOGICAL ENDOCRINOLOGY, 2015, 31 (10) : 796 - 800
  • [4] S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways
    Duan, Liang
    Wu, Rui
    Zou, Zhengyu
    Wang, Haiyan
    Ye, Liwei
    Li, Huan
    Yuan, Shimei
    Li, Xueru
    Zha, He
    Sun, Hui
    Zhang, Yunyuan
    Chen, Xian
    Zhou, Lan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 781 - 790
  • [5] Ubiquitin D promotes the progression of rheumatoid arthritis via activation of the p38 MAPK pathway
    Chen, Hong
    Tao, Liju
    Liang, Juhua
    Pan, Chunfeng
    Wei, Hua
    MOLECULAR MEDICINE REPORTS, 2023, 27 (02)
  • [6] S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway
    Li, Aifang
    Gu, Yue
    Li, Xueru
    Sun, Hui
    Zha, He
    Xie, Jiaqing
    Zhao, Jiali
    Huang, Mao
    Chen, Lu
    Peng, Qi
    Zhang, Yan
    Weng, Yaguang
    Zhou, Lan
    ONCOLOGY LETTERS, 2018, 15 (04) : 5685 - 5693
  • [7] Ginkgetin promotes proliferation and migration of Schwann cells via PIGF/p38 MAPK signaling pathway
    Zhang, Yong
    Niu, Yanfen
    Weng, Qiuyan
    TISSUE & CELL, 2022, 79
  • [8] Ginkgetin promotes proliferation and migration of Schwann cells via PIGF/ p38 MAPK signaling pathway
    Zhang, Yong
    Niu, Yanfen
    Weng, Qiuyan
    TISSUE & CELL, 2022, 79
  • [9] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway
    Wu, Rui
    Duan, Liang
    Ye, Liwei
    Wang, Haiyang
    Yang, Xia
    Zhang, Yunyuan
    Chen, Xian
    Zhang, Yan
    Weng, Yaguang
    Luo, Jingyong
    Tang, Min
    Shi, Qiong
    He, Tongchuan
    Zhou, Lan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (03) : 1001 - 1010
  • [10] Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation
    Xu, Shengkai
    Wen, Huazhi
    Jiang, Hong
    MOLECULAR MEDICINE REPORTS, 2012, 6 (01) : 197 - 200